Announcements Trials
Browse Landscape

Phase

Phase NA 25Phase 3 3Phase 4 2Phase 2/3 2Phase 2 1

Status

Unknown 6Recruiting 3Terminated 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 2Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Nasopharyngeal Carcinoma 1Breast Neoplasms 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Control Groups × Clear all
NCT06235203 2025-06-03

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Eye & ENT Hospital of Fudan University

Phase 3 Recruiting
154 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05063136 2024-11-04

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Henan Cancer Hospital

Phase 3 Recruiting
1,979 enrolled
Breast

Breast Neoplasms

NCT06248996 2024-09-19

ARTSCAN VI

Lund University Hospital

Phase 3 Recruiting
308 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡